ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Premium IconPremium Help Menu
DAX
24.944,95
0,54%
S&P 500
7.584,31
0,41%
Dow Jones
51.561,93
1,73%
Euro vs US Dollar
1,16148
0,02%
Bitcoin
61.628,80
-3,42%
Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Insidergeschäfte

Amgen Inc

Amgen Inc (AMGN)

Amgen CDR
Amgen Inc
345,60
7,38
(2,18%)
Geschlossen 05 Juni 10:00PM
346,9839
1,38
(0,40%)
Nach Börsenschluss: 1:56AM

Amgen Inc (AMGN) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-05-07Mr. Matthew C. BuschCAO & VP of Finance-41,0013,58kSale to Issuer331,113,15k-1,29%
2026-05-07Mr. Esteban SantosExec. VP of Operations-522,00172,84kSale to Issuer331,1175,32k-0,69%
2026-05-07Dr. David M. ReeseExec. VP & CTO-556,00184,10kSale to Issuer331,1133,24k-1,64%
2026-05-07Mr. Derek MillerSVP of HR-151,0050,00kSale to Issuer331,119,86k-1,51%
2026-05-07Ms. Rachna KhoslaSVP of Business Development-93,0030,79kSale to Issuer331,116,88k-1,33%
2026-05-07Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO-88,0029,14kSale to Issuer331,115,96k-1,46%
2026-05-07Mr. Peter H. GriffithExec. VP & CFO-556,00184,10kSale to Issuer331,1140,13k-1,37%
2026-05-07Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary-499,00165,22kSale to Issuer331,1131,65k-1,55%
2026-05-07Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy-615,00203,63kSale to Issuer331,1140,84k-1,48%
2026-05-07Mr. Robert A. BradwayChairman & CEO-2,08k688,38kSale to Issuer331,11620,48k-0,33%
2026-05-07Dr. James E. BradnerEVP of Research & Development, Artificial Intelligence and Data-446,00147,68kSale to Issuer331,117,10k-5,91%
2026-05-06Dr. James E. BradnerEVP of Research & Development, Artificial Intelligence and Data-407,00134,14kSale to Issuer329,596,60k-5,81%
2026-05-06Mr. Robert A. BradwayChairman & CEO-1,70k560,96kSale to Issuer329,59618,61k-0,27%
2026-05-06Mr. Matthew C. BuschCAO & VP of Finance-50,0016,48kSale to Issuer329,593,08k-1,60%
2026-05-06Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy-502,00165,45kSale to Issuer329,5940,29k-1,23%
2026-05-06Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary-408,00134,47kSale to Issuer329,5931,20k-1,29%
2026-05-06Mr. Peter H. GriffithExec. VP & CFO-502,00165,45kSale to Issuer329,5939,63k-1,25%
2026-05-06Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO-76,0025,05kSale to Issuer329,595,88k-1,28%
2026-05-06Ms. Rachna KhoslaSVP of Business Development-79,0026,04kSale to Issuer329,596,80k-1,15%
2026-05-06Mr. Derek MillerSVP of HR-123,0040,54kSale to Issuer329,599,72k-1,25%
2026-05-06Dr. David M. ReeseExec. VP & CTO-454,00149,63kSale to Issuer329,5932,75k-1,37%
2026-05-06Mr. Esteban SantosExec. VP of Operations-427,00140,73kSale to Issuer329,5974,85k-0,57%
2026-05-02Mr. Esteban SantosExec. VP of Operations-1,34k441,30kSale to Issuer329,8274,44k-1,77%
2026-05-02Dr. David M. ReeseExec. VP & CTO-1,43k472,63kSale to Issuer329,8232,31k-4,25%
2026-05-02Mr. Derek MillerSVP of HR-365,00120,38kSale to Issuer329,829,61k-3,66%
2026-05-02Ms. Rachna KhoslaSVP of Business Development-225,0074,21kSale to Issuer329,826,72k-3,24%
2026-05-04Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO-1,24k400,45kVerkauf323,735,81k-17,56%
2026-05-02Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO-242,0079,82kSale to Issuer329,825,81k-4,00%
2026-05-02Mr. Peter H. GriffithExec. VP & CFO-1,43k472,63kSale to Issuer329,8239,16k-3,53%
2026-05-02Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary-1,26k414,58kSale to Issuer329,8230,81k-3,92%
2026-05-02Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy-1,59k525,40kSale to Issuer329,8239,81k-3,85%
2026-05-02Mr. Matthew C. BuschCAO & VP of Finance-68,0022,43kSale to Issuer329,822,99k-2,22%
2026-05-02Mr. Robert A. BradwayChairman & CEO-5,06k1,67MSale to Issuer329,82616,98k-0,81%
2026-03-16Mr. Esteban SantosExec. VP of Operations-5,62k2,06MSale to Issuer366,2173,37k-7,12%
2026-03-16Dr. David M. ReeseExec. VP & CTO-6,02k2,21MSale to Issuer366,2131,16k-16,20%
2026-03-16Mr. Derek MillerSVP of HR-1,62k591,80kSale to Issuer366,219,31k-14,78%
2026-03-16Ms. Rachna KhoslaSVP of Business Development-707,00258,91kSale to Issuer366,216,54k-9,75%
2026-03-16Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO-787,00288,21kSale to Issuer366,216,86k-10,29%
2026-03-16Mr. Peter H. GriffithExec. VP & CFO-5,75k2,10MSale to Issuer366,2138,01k-13,14%
2026-03-16Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary-5,35k1,96MSale to Issuer366,2129,80k-15,23%
2026-03-16Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy-6,69k2,45MSale to Issuer366,2138,53k-14,80%
2026-03-16Mr. Robert A. BradwayChairman & CEO-21,29k7,80MSale to Issuer366,21612,90k-3,36%
2026-03-16Mr. Matthew C. BuschCAO & VP of Finance-327,00119,75kSale to Issuer366,212,89k-10,17%
2026-03-04Mr. Robert A. BradwayChairman & CEO35,50k5,55MDerivative Exercise and Retained Stock156,35633,62k5,93%
2026-03-04Mr. Robert A. BradwayChairman & CEO-84,29k18,79MDerivative Exercise and Sale156,35 - 379,27633,62k-
2026-02-26Mr. Esteban SantosExec. VP of Operations-54,79k11,50MDerivative Exercise and Sale162,60 - 379,1268,16k-
2026-02-19Mr. Matthew C. BuschCAO & VP of Finance-1.000,00375,79kVerkauf375,792,26k-30,64%
2026-02-09Dr. James E. BradnerEVP of Research & Development, Artificial Intelligence and Data-3,10k1,19MSale to Issuer384,3215,21k-16,95%
2025-11-20Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO-3,14k525,98kDerivative Exercise and Sale162,60 - 337,265,59k-
2025-11-12Ms. Rachna KhoslaSVP of Business Development-890,00299,26kVerkauf336,245,04k-15,02%
2025-11-12Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy-6,88k2,32MVerkauf336,8329,52k-18,90%
2025-11-11Dr. David M. ReeseExec. VP & CTO-6,80k0,00Other Disposition-23,90k-22,15%
2025-11-05Ms. Rachna KhoslaSVP of Business Development-226,0067,05kSale to Issuer296,706,02k-3,62%
2025-11-05Mr. Matthew C. BuschCAO & VP of Finance-202,0059,93kSale to Issuer296,703,11k-6,10%
2025-08-20Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO-1,27k376,28kVerkauf296,995,58k-18,51%
2025-06-05Ms. Rachna KhoslaSVP of Business Development-1,50k434,52kVerkauf289,685,91k-20,25%

Kürzlich von Ihnen besucht

NASDAQ
AMGN
Amgen
Delayed Upgrade Clock
ADVFN
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2026 ADVFN Ltd - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten